Hannah E. Dzimitrowicz, MD, Duke Cancer Center, Durham, NC, discusses the need for further clinical trials and large cohort studies to investigate the effects of the COVID-19 vaccine on patients with cancer, especially those undergoing immunotherapy. This interview took place during the 36th Society for Immunotherapy of Cancer (SITC) Annual Meeting in Washington, D.C.
